Saturday, March 18, 2006


Hepatitis C Virus Infection in Cocaine Users: A Silent Epidemic (Hep C Treatment)


Hepatitis C Virus Infection in Cocaine Users: A Silent Epidemic
The presence of Hepatitis C infection in cocaine users who thought they were healthy suggests a silent epidemic in an unsuspecting population.

Hepatitis C: Tattoo | CDC Viral Hepatitis
CDC's Position on Tattooing and HCV Infection. Although some studies have found an association between tattooing and HCV infection in very selected ...

P4042 If you have hepatitis C, which vaccinations do you need?
P4042 This chart is for patients, and shows which vaccinations one needs if they have hepatitis C.

Hepatitis C: Plan: Infection | CDC Viral Hepatitis
Hepatitis C Infection in the United States. Hepatitis C virus (HCV) infection is the most common chronic bloodborne viral infection in the United States. ...

Damned Treatment, Damn Mum (Hep C Treatment)


Damned Treatment, Damn Mum
We did that then we got in the car to go to the Hep C trust with my mum. When we where in the car we started talking and i realised the implications of not reacting to the to the treatment, one thing

Hep C Boy My Hep C
Includes Hep C news, tips and links. Reminder: I am not a Doctor, these are my views, use at your own risk and consult your medical people before taking any action

Hep C: Sources of Information
An Extensive Listing of State Hep C Support Groups Can Be Found

Methadone Anonymous -- View Forum - HIV / HCV in the News
Marijuana just how bad is it for us with Hep C??? truetildeath13 4 758 Sun Jan 15, 2006 3:39 pm korshoski HIV Tracking System May Be Scrapped Bev 0 359 Tue Jul 26, 2005 10:04 am

Measuring Success of Hep C Treatment HepCFight.com
Get hep C information you can use today including details about hep C treatments and services.

Hep C Plymouth Homepage
Welcome To Hep C Plymouth.net The Impact Of A Hepatitis C Diagnosis On Treatment For Substance Use

Thursday, March 16, 2006


What is Hepatitis C?(NC)-Hepatitis C is an infectious (Hep C Treatment)

What is Hepatitis C?

(NC)-Hepatitis C is an infectious virus that is carried in the blood and harms the liver. About 240,000 Canadians are infected, many of whom are unaware that they even have it. The number of people with hepatitis C is increasing in Canada and around the world, primarily among those who share needles and other drug equipment. An estimated 5,000 Canadians - mostly young people - get this virus each year. p>

Although the hepatitis C virus has been around for a long time, it was only identified in 1989. It causes inflammation of the liver, which often progresses to cirrhosis (scarring that makes it difficult for the liver to function normally). Of the estimated 5,000 people that are newly infected each year, up to 70 percent experience no symptoms. For some, symptoms may not show up for 20 or 30 years. In the meantime, they may, unknowingly, be infecting others. That is why it is important to know if you are at risk and how to take preventative action.

If you think you have hepatitis C, or that you may be at risk, visit your doctor and ask for the simple blood test for this disease. For more information, contact a health care professional, and visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.



Third Wave, Chiron, Bayer Dismiss HCV Patent Suit (Hep C Treatment)


Third Wave, Chiron, Bayer Dismiss HCV Patent Suit
[Press Release] PR Newswire via Yahoo! Finance - Feb 23 5:00 AM
Third Wave Technologies Inc. today announced that it has reached an agreement with Chiron Corp., Bayer Corp., and Bayer HealthCare, LLC under which the companies jointly will seek the dismissal without prejudice of Third Wave's lawsuit against Chiron and Bayer over patents related to hepatitis C virus, or HCV.Save to My Web

Popular Science Magazine Features The Aethlon Hemopurifier(TM)
[Press Release] Business Wire via Yahoo! Finance - Mar 14 4:00 AM
SAN DIEGO----March 14, 2006--Aethlon Medical, Inc. , a pioneer in developing therapeutic devices for infectious disease, announced today that its Hemopurifier treatment technology is featured in the April issue of Popular Science Magazine.Save to My Web

InterMune to Present at the Bear Biotech West Coast Confab
[Press Release] PR Newswire via Yahoo! Finance - Mar 16 2:08 PM
InterMune, Inc. announced today that it will present a corporate overview at the Bear Biotech West Coast Confab in San Francisco, CA on Thursday, March 23, 2006 at 2:00 p.m. PST.Save to My Web

Coley Pharmaceutical Group Initiates Phase II Clinical Study of ... (Hep C Treatment)


Coley Pharmaceutical Group Initiates Phase II Clinical Study of ...
PR Newswire (press release), NY - Feb 23, 2006... announced the initiation of a randomized Phase II clinical study of Actilon(TM) (CPG 10101) for the treatment of patients with chronic Hepatitis C infection. ...

Human Genome Sciences: challenging the pegylated interferons
Pharmaceutical Business Review - 10 hours ago... Chronic hepatitis C (CHC) is currently managed through combination therapy consisting of pegylated interferon (pegIFN) and ribavirin (RBV), marketed by Roche ...

China drugs firm Phynova rallies
ShareCast, UK - Feb 27, 2006... Phynova is currently developing six drug candidates, one for relief of the symptoms of chronic hepatitis C, one for the hepatitis virus, and others for obesity ...

New hope for Hepatitis C patients
Trade Arabia, Bahrain - Feb 25, 2006... the results of a study on the efficacy and tolerability of Pegasys with or without Ribavirin in Thalassaemia Major patients with chronic Hepatitis C. The study ...

Wednesday, March 15, 2006


Daily Planner: Monday (Hep C Treatment)


Daily Planner: Monday
Chico Enterprise-Record - SIERRA NEVADA BREWING CO.'s BIG ROOM: 7 p.m. Live music by the Steve Cook Band (Cook, Jimmy Fay, Ska-T, Kim Gimbal, Jerry Morano.) $5 at the door. MIKELESS OPEN MIKE: 8 p.m. Has Beans, 501 Main St. Spoken word performances. Ongoing. Community BLOOD

Medical Myth Busting
NHPR - listen: No audio currently available. Order on CD (pdf). An estimated fifteen to twenty five thousand people in New Hampshire have Hepatitis C. The virus is the most common blood borne infection in the United States and the leading cause of liver

no comment
East Side Boxing - This is a place to express your boxing views. It is not a place to offend anyone. If we feel comments are aimed to offend, the post will be deleted and the offenders IP address will be logged and access blocked. We will not tolerate foul language or


Viral Hepatitis (Hep C Treatment)


Viral Hepatitis
viral hepatits viral hepatitiis viral hepatiti viral hepatitiss ivral hepatitis vrial hepatitis viarl hepatitis virla hepatitis vira lhepatitis viralh epatitis viral ehpatitis viral hpeatitis viral heaptitis viral

hbv_research
Immunization Rates Remain Less than Half for Gay and Bisexual Men 23-Oct-2002 Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B 23-Oct

Drug Information from The Anti-Aging Revolution: Anti-Aging, Bio
Lamivudine does not increase the efficacy of interferon in the treatment of mutant type chronic viral heaptitis B. Yang SS, Hsu CT, Hu JT, Lai YC, Wu CH World Journal of Gastroenterology Volume 8

Nurses and Hepatitis C
Officers Coinfection HIV & Viral Heaptitis: a guide December 2003 Third Edition Produced in Association with the Australian Liver Association, Gastroenterological Society of Australia

Tuesday, March 14, 2006


Hickey to run Boston Marathon for American Liver Foundation (Hep C Treatment)


Hickey to run Boston Marathon for American Liver Foundation
Hingham Journal, MA - Mar 2, 2006... hepatitis being the most common. Four million Americans have chronic hepatitis C and most do not know it. Inheritable liver diseases are ...

Human Genome Sciences: Human Genome Sciences Reports Financial ...
Webbolt Business News (subscription), Canada - Feb 13, 2006... November 2005, HGS reported the interim results of a Phase 2 trial of Albuferon in combination with ribavirin in patients with chronic hepatitis C who failed ...

Hep C key lies in new needles, not education
Australian, Australia - Feb 19, 2006... About 75 per cent of people infected are likely to progress to chronic hepatitis C, with the virus in the bloodstream for more than six months. ...

Peregrine Pharmaceutical Will Deliver Hepatitus C Phase I Safety ...
Medical News Today (press release), UK - Feb 22, 2006... planned patient enrollment and dosing in its initial Phase l clinical trial for Tarvacin(TM) Anti-Viral in the treatment of chronic hepatitis C virus infection ...

Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2005 ... (Hep C Treatment)


Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2005 ...
PR Newswire (press release), NY - Feb 23, 2006... ANA975 designed to evaluate the safety and tolerability of ANA975 and the viral load reduction achieved in patients with chronic hepatitis C over 28 days. ...

MIGENIX Reports Third Quarter Fiscal Year 2006 Results
MSN Money - Mar 8, 2006... development programs, with two phase II clinical outcomes expected this year in our MX-3253 program for the treatment of chronic hepatitis C virus infections ...

Toll-like receptor therapies compete to reduce side effects
Nature.com (subscription), UK - Mar 6, 2006... CSO, claims that ANA975, the company's TLR7 agonist, recently tested in a 28-day clinical trial involving patients with chronic hepatitis C, could produce ...

Nature Reviews Drug Discovery Writes On AVI BioPharma's NEUGENE ...
Trading Markets, CA - Mar 7, 2006... AVI is currently enrolling patients with chronic hepatitis C infection in a Phase I/II clinical trial in the US The company has also reported early success in ...

Human Genome Sciences up on drug outlook
BusinessWeek - Mar 1, 2006... on Wednesday after the company presented at an investor conference and provided an "upbeat" outlook for Albuferon, a possible treatment for chronic hepatitis C ...

Monday, March 13, 2006


Hep - Hep C Aware - ARE YOU? (Hep C Treatment)


Hep - Hep C Aware - ARE YOU?
... philip r craig. hep c treatment. supply manufacturing randolph ...

Peter's Hep C Links
Peter's Hep C Links. General Info. Support. Forums. Treatment. News. Blogs. They also served... Alcohol & Drug Abuse Recovery. Complementary Medicine. Mental Health. General Medicine

POZ - - Hep Cat- by Tim Murphy - May #112
... and support programs for coinfecteds undergoing hep C treatment to the many states whose AIDS ... Before you start hep C treatment (which combines pegylated interferon with ribavirin ...

News Review
... We'll also look at how to integrate Hep C treatment, discuss treatment guidelines and learn about the ... ongoing litigation, any inmate needing hep C treatment who had a history ...

Hep C Treatment
New treatment for Hepatitis C looks promising. HOUSTON--(Jan.

Heart And Soul: Me 'n' Hep C
Heart And Soul: Me 'n' Hep C. Recovering alcoholic and addict with hepatitis C, genotype 2B. Treatment with interferon (180mcg/week) and ribavarin (1g daily) 15 Feb 05 through 11 May 05.

Hep C treatment didn't work-wife is having hard time coping - HealingWell.com Forum (Hep C Treatment)


Hep C treatment didn't work-wife is having hard time coping - HealingWell.com Forum
... HealingWell.com Forum > Diseases & Conditions > Hepatitis > Hep C treatment didn't work-wife is having hard time ... has undergone six months of Hep C treatment last year, which did ...

Writing.Com: ME AND MY HEP C
(Part 1)My Dance With The Dragon ... So far 2004 is off to a good start. HEP C TREATMENT. Weapon to Battle the Dragon ...

Re: Hep C & Treatment
Message Boards on Health Related Topics. --> hepatitis message board. Re: Hep C & Treatment. FREE HealthBoards.com info from vendors! Select: Signup. Hepatitis - new products and services ... In Reply to: Re: Hep C & Treatment posted by Eric on September 28, 2000 at 12:52:48 ...

Hepatitis C Harm Reduction Project
... I periodically get questions about financial assistance for hep C treatment from people who don't have health insurance ...

Hepatitis C Virus Lives In Your Liver(NC)-Your liver (Hep C Treatment)

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>



Viral hepatitis C management involves some tough decisions (Hep C Treatment)


Viral hepatitis C management involves some tough decisions
Managed Healthcare Executive - From a care delivery standpoint, identifying and treating patients with the hepatitis C virus (HCV) is a complicated and difficult process. It's the most prevalent liver disease in the world, with as many as 300 million people afflicted with the


Indenix is Nearing Phase III for Valopicitabine (Hep C Treatment)


Indenix is Nearing Phase III for Valopicitabine
It is always good to see progress with alternatives to current medical therapy for HCV. Even though companies that are working on solutions to be used with interferon are not really offering anything groundbreaking or revolutionary, it does continue the...

A Breakthrough Discovery for Hepatitis C
The state of Florida has recently produced a study illuminating the replication and mutation of the Hepatitis C virus. This kind of progress represents a giant leap forward in tracking this persistent virus, which likely means more accurate and efficient...

Primary Biliary Cirrhosis
Title: Primary Biliary CirrhosisCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Peregrine Announces Completion of Planned Patient Enrollment and Dosing in Initial Tarvacin(TM) Anti-Viral Hepatitis C (Hep C Treatment)


Peregrine Announces Completion of Planned Patient Enrollment and Dosing in Initial Tarvacin(TM) Anti-Viral Hepatitis C
[Press Release] PR Newswire via Yahoo! Finance - Feb 15 4:00 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has completed planned patient enrollment and dosing in its initial Phase l clinical trial for Tarvacin Anti-Viral in the treatment of chronic hepatitis C virus infection .Save to My Web

A Summary of Chronic Hepatitis C InfectionHepatitis C (Hep C Treatment)

A Summary of Chronic Hepatitis C Infection

Hepatitis C is a stealthy virus that mutates while hiding in liver cells and other organ cells like the spleen and gall bladder. The fact that the viral cells "hide" makes it very difficult for the body's immune system to eradicate it. Hepatitis C is a slowly progressing disease sometimes taking many years until symptoms are noticeable. It is at this point that the virus has reached advanced chronic stage and becomes difficult to eradicate. Hepatitis C results in 8,000 to 10,000 deaths annually. Hepatitis C is also the leading cause of liver transplants in the U.S.

Hepatitis C infection is caused by blood contact with someone who has the virus infection himself. The transmission of the virus can occur by illicit drug use with needles, sharing toothbrushes or razors with an infected person, by sexual means, by unsanitary tattooing or by exposure to blood at your workplace (like a hospital or blood bank). Some HCV infection may have been caused by receiving blood from a transfusion prior to 1992.

Hepatitis C is diagnosed via a blood test. Usually, the first thing that is noticed is that the liver enzyme levels for ALT and AST are elevated well above normal levels. Further investigation via HCV-RNA testing identifies whether the Hepatitis C virus is in your blood or not. Other tests for HCV include qualitative viral load tests, which measure the RNA particles in your blood. If you are being treated for HCV, your doctor is probably using either a HCV-RNA or viral load test to determine the effectiveness of the treatment.

The symptoms of Hepatitis C infection often do not occur in a person until 20 years after he/she had been infected. Since the HCV infects the liver and the liver is the organ in the body that makes all the energy for our daily activities possible, liver function deterioration often results in fatigue. Fatigue is the primary complaint or symptom of HCV infection. Other more severe symptoms are jaundice (yellowing of the skin/eyes), bile retention (which can cause jaundice), portal vein hypertension, skin rashes and itching, and autoimmune problems resulting from your body's immune system attacking normal cells.

Long term HCV infection may result in fibrosis or even cirrhosis of the liver. Fibrosis results from unchecked liver inflammation. As the HCV infection progresses, the damage to the liver results in scarring or hardening of the liver cells (fibrosis). Long term fibrosis may lead to cirrhosis which is when the scarring from fibrosis overtakes the normal liver cell structure causing deformity and loss of function in the liver. About 15%-20% of HCV patients end up with cirrhosis. A liver biopsy is currently the most accurate means of determining the amount of inflammation and fibrosis the liver has sustained.

Hepatitis C progression in the body can take several years or even decades to come to chronic stage or to a stage where severe liver damage is evident. This period of time allows a person to determine how to properly treat the disease and to decide on a course of disease management. Currently, the main treatment for HCV infection to eradicate the virus is combo alpha-interferon and Ribavirin. Sometimes a doctor may prescribe interferon alone. Interferon comes in standard form or in pegylated form. Standard form interferon is administered 3 times per week, while the pegylated form is administered only once per week. Your body makes its own interferon, which is a protein that fights viral infection and viral replication.

Hepatitis C may often be managed by taking herbal and vitamin supplements that help your body fight infection and limit inflammation. These supplements help your liver with the inflammation and give it the nutrients it needs to regenerate healthy new cells. Your doctor can recommend alternative or adjunct solutions you may want to try.

Proper treatment of the disease, a healthy and active lifestyle, a good diet, abstinence from alcohol and stress management are important factors in controlling Hepatitis C progression.

About the Author

Greg Lietz is a freelance writer and internet businessman. His main website is http://www.theonlinebizplace.com where he provides content about internet based business opportunities and different niche interests. This article may be freely printed when the bio information is included.

euro adhoc: Intercell AG / Financial Figures (Hep C Treatment)


euro adhoc: Intercell AG / Financial Figures
VWDNews - Vienna (Austria), March 6, 2006 - Vaccine company Intercell AG (VSE: ICLL) today announced its preliminary 2005 full year results. Intercell?s aggregate annual revenues increased from EUR 4.6 million in 2004 to EUR 8.5 million in 2005, or by 84.9


Human Genome Sciences up on drug outlook (Hep C Treatment)


Human Genome Sciences up on drug outlook
BusinessWeek - Mar 1, 2006... on Wednesday after the company presented at an investor conference and provided an "upbeat" outlook for Albuferon, a possible treatment for chronic hepatitis C ...

Intercell announces preliminary 2005 full year results: Good ...
news aktuell (Pressemitteilung), Germany - Mar 5, 2006... these results, Intercell is now planning to test IC41 with this optimized schedule in a further Phase II trial in patients with chronic Hepatitis C. This study ...

AVI BioPharma Successful Ebola Study Results Highlighted in Nature ...
Genetic Engineering News, NY - Mar 7, 2006... infections.". AVI is currently enrolling patients with chronic hepatitis C infection in a Phase I/II clinical trial in the United States. ...

Clinical Trial Results Show That Peregrine's First-In-Class Anti ...
International News Service, Australia - Feb 27, 2006... that its first-in-class anti-viral compound Tarvacin(TM) Anti-Viral appeared safe and well-tolerated in a Phase l study in chronic hepatitis C virus (HCV ...

MIGENIX to Participate in "Breakthroughs in Hepatitis" Focus ...
Canada NewsWire (press release), Canada - Feb 13, 2006... and will present MIGENIX's celgosivir (MX-3253), a first-in-class alpha glucosidase 1 inhibitor for the treatment of chronic Hepatitis C infections. ...

CROI: rapid response predicts success in HIV/HCV coinfected ...
Aidsmap, UK - Feb 17, 2006... Utility of the early viral response to individually-adjust the duration of treatment for chronic hepatitis C, genotype 2 or 3, in HIV-coinfected patients. ...

Hepatitis C: Early Detection Means Better Health(NC)-Experts estimate (Hep C Treatment)

Hepatitis C: Early Detection Means Better Health

(NC)-Experts estimate that 240,000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus. The only way to find out for sure if you have hepatitis C is through a blood test. Your doctor can order one for you. By taking this action you'll be doing yourself a favour because hepatitis C can be treated only if it has been detected. Untreated hepatitis C can lead to severe conditions that require long-term, intensive care.

For more information visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.



Putting a face on the AIDS tragedy (Hep C Treatment)


Putting a face on the AIDS tragedy
Toronto Star, Canada - Feb 23, 2006... was around the middle of 1985 that the reality of AIDS was descending upon Canada's hemophiliac community, says John Plater, chair of the HIV/Hep C Task Force ...

Northern Ocean Support Groups
Asbury Park Press, NJ - Feb 25, 2006... HEP-C SUPPORT: MOCHCCI-Hepatitis C support group meets 7-9 pm the first Tuesday of the month in the lower-level conference room at Ocean Medical Center, 425 ...

Tainted blood trial in doubt
Toronto Star, Canada - Feb 14, 2006... Although not proceeding on charges against the doctors would be upsetting, John Plater, chair of the HIV/Hep C Task Force for the Canadian Hemophilia Society ...

Hep C key lies in new needles, not education
Australian, Australia - Feb 19, 2006PROVIDING clean needles to injecting drug users is almost four times more effective in fighting the rising epidemic of hepatitis C than the education and ...

Hepatitis C: serum viral levels recur rapidly after liver ... (Hep C Treatment)


Hepatitis C: serum viral levels recur rapidly after liver ...
Xagena.it, Italy - Mar 2, 2006When a diseased liver is removed from a patient with Hepatitis C (HCV), serum viral levels plummet. However, after receiving a healthy ...

MIGENIX to Participate in "Breakthroughs in Hepatitis" Focus ...
Canada NewsWire (press release), Canada - Feb 13, 2006... About Celgosivir MX-3253 (celgosivir) is an alpha-glucosidase I inhibitor in Phase II development and is currently the only oral anti-HCV drug in clinical ...

Third Wave agrees to drop Chiron, Bayer patent lawsuits
WTN News, WI - Feb 23, 2006... Third Wave resolved its lawsuit with Innogenetics NV in early February by buying a non-exclusive license to that company's HCV patent after evaluating the cost ...

Hepatitis B (Hep C Treatment)


Hepatitis B
Title: Hepatitis BCategory: Diseases and ConditionsCreated: 1/26/2001 11:58:00 AMLast Editorial Review: 9/21/2005

Doctor: Checklist to Take To Your Doctor's Appointment
Title: Doctor: Checklist to Take To Your Doctor's AppointmentCategory: Health FactsCreated: 7/13/2005Last Editorial Review: 7/14/2005

Healthy Habits: What Your Doctor Wants You To Know
Title: Healthy Habits: What Your Doctor Wants You To KnowCategory: Doctor's ViewsCreated: 12/9/2005Last Editorial Review: 12/22/2005

Magnetic Resonance Imaging (MRI Scan)
Title: Magnetic Resonance Imaging (MRI Scan)Category: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 8/31/2005

Is There A Vaccine For Hepatitis C?(NC)-No, not (Hep C Treatment)

Is There A Vaccine For Hepatitis C?

(NC)-No, not for hepatitis C. There are vaccines for hepatitis A and hepatitis B. To prevent further damage to your liver, your doctor may advise you to be vaccinated against hepatitis A and hepatitis B.

Could I give hepatitis C to someone else?

Yes, as far as we know, once you have hepatitis C, you can always transmit it to someone else if they come in contact with your blood. If you have hepatitis C, you can't donate blood. You should avoid sharing personal items like razors and toothbrushes, because the virus is spread through blood to blood contact.

Although the virus isn't spread easily by sexual contact or from a mother to her unborn baby, the risk of transmitting the virus is not absent. Therefore, talk to your doctor first if you want to have children. p>

For more information on hepatitis C visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.



FIRSTConsult - Viral hepatitis C - Medical Topic File (Hep C Treatment)


FIRSTConsult - Viral hepatitis C - Medical Topic File
FIRSTConsult, Viral hepatitis C (Medical Topic File). Published for medical students and primary healthcare providers by Elsevier.

Hepatitis C and Complementary and Alternative Medicine
The authors concluded "glycyrrhizin is a potential drug in reducing long-term complications in chronic viral hepatitis C in patients who do not respond with ...

Hepatitis C: Current Treatment
... more research is definitely needed to develop safer, more effective and cheaper drugs (see Evolving Treatments for Chronic Viral Hepatitis C). ...

Chronic Viral Hepatitis
Viral Hepatitis C: Formerly known as "non-A, non-B Hepatitis." This form of viral hepatitis is the most common. It can be spread through blood transfusions ...

Glucocorticosteroids for viral hepatitis C (Cochrane Review)
Abstract of a systematic review of the effects of health care prepared by the Cochrane Collaboration.

National HCV Prison Coalition - Hepatitis C Awareness Project (Hep C Treatment)


National HCV Prison Coalition - Hepatitis C Awareness Project
The National Hepatitis C Prison Coalition provides support to prison inmates who are suffering from hepatitis C (HCV) and HIV/HCV coinfection.

Hepatitis C Top Articles
Chronic hepatitis C virus (HCV) infection affects approximately 3 million people in ... Is HCV Viral Load a Predictor of Progression of Chronic Hepatitis C? ...

Hepatitis C: Index | CDC Viral Hepatitis
HIV/HCV Co-infection Center of Excellence: a national resource on HIV/HCV co-infection for clinicians and health professionals. StopHep. ...

HCV Wireless
Kompakar & HCV Wireless In Partnership To Launch Fixed-Mobile Convergence ... Alcatel have partnered with HCV Wireless to deliver Fixed Mobile Convergence ...

www.tulane.edu/~dmsander/WWW/335/HCV.html
Similar pages HCV Hepatitis C Anonymous - 12 Steps - Home Page - Hep C Virus ... HCV Hepatitis Anonymous supplies current hepatitis news & information on Hepatitis C (HCV), 12 steps, big book, positive attitudes, online HCV meetings and ...

HCV ANONYMOUS - Index
A support forum for those who are not infected - But affected by HCV. ... Review HCV and health realted books here. Tell everbody what you really thought of ...

America's Blood Centers :: HCV Lookback (Hep C Treatment)


America's Blood Centers :: HCV Lookback
Statement of support for blood safety measures, including HCV Lookback. 1-888-USBLOOD

Idenix Pharmaceuticals: HCV
Hepatitis C is an infectious liver disease caused by the hepatitis C virus (HCV). HCV infection becomes chronic in 75 to 85 percent 1 of individuals after their initial infection

America's Blood Centers :: HCV Lookback
Statement by ABC in support of FDA HCV Lookback policies. 1-888-USBLOOD

HCV
HCV Patient Summary Taurox therapy reduced the fatigue in patients infected with HCV. While additional studies are needed to fully elucidate the mechanism of action of Taurox, the reduction in